Obstructive and Central Sleep Apnoea

This book will be published in September 2026. It will be available to pre-order in July 2026.

Edited by Winfried Randerath, Jean-Louis Pepin and Sophia Schiza

Contents list (subject to change)
1. Patients' perspective
2. Obesity, environment, global warming: current epidemiology and perspectives in modulating SDB burden in 2050
3. The impact of obesity: obstruction, inflammation, endocrine function
4. The pathophysiological traits: what do we know? What do we miss?
5. Mechanisms, biomarkers and clinical manifestations of vascular damage
6. OSA and oncogenesis – is there evidence?
7. Patient-reported outcomes, daytime performance, and neuro-psychiatric symptoms
8. AHI, hypoxia, autonomic arousals, pulse wave, heart rate variability: what does matter?
9. OSA in females
10. Cluster analysis: relevance for phenotyping and outcome
11. OSA and insomnia (COMISA)
12. COPD-OSA overlap, IPF-OSA
13. Obesity hypoventilation
14. Integrative concepts of classification and treatment decision
15. Technological innovations and artificial intelligence for end-to-end diagnostical, treatment and follow-up pathways
16. Wearables, single-channel screening, polygraphy, polysomnography: why, were, how?
17. Multiple-night diagnosis: a revolution in the field?
18. Obesity management: behaviour, drugs, surgery
19. Positive airway pressure (PAP) therapies – indication, selection and management
20. Non-PAP therapies: from orthodontics to surgery
21. Towards a new area: pharmaceutical treatments and combination therapy
22. Epidemiology, entities and pathophysiological concepts
23. Diagnostical tools (differentiation of hypopnoeas, hypercapnic/hypoxic chemoresponsiveness)
24. Treatment: oxygen, drugs, PAP

Print ISBN: 978-1-84984-214-3
eISBN: 978-1-84984-215-0
EPUB ISBN: 978-1-84984-216-7